Year |
Citation |
Score |
2022 |
Mätlik K, Garton DR, Montaño-Rodríguez AR, Olfat S, Eren F, Casserly L, Damdimopoulos A, Panhelainen A, Porokuokka LL, Kopra JJ, Turconi G, Schweizer N, Bereczki E, Piehl F, Engberg G, et al. Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia. Molecular Psychiatry. PMID 35618883 DOI: 10.1038/s41380-022-01554-2 |
0.333 |
|
2020 |
Morello F, Voikar V, Parkkinen P, Panhelainen A, Rosenholm M, Makkonen A, Rantamäki T, Piepponen P, Aitta-Aho T, Partanen J. ADHD-like behaviors caused by inactivation of a transcription factor controlling the balance of inhibitory and excitatory neuron development in the mouse anterior brainstem. Translational Psychiatry. 10: 357. PMID 33087695 DOI: 10.1038/s41398-020-01033-8 |
0.751 |
|
2019 |
Lindahl M, Chalazonitis A, Palm E, Pakarinen E, Danilova T, Pham TD, Setlik W, Rao M, Võikar V, Huotari J, Kopra J, Andressoo JO, Piepponen PT, Airavaara M, Panhelainen A, et al. Cerebral dopamine neurotrophic factor-deficiency leads to degeneration of enteric neurons and altered brain dopamine neuronal function in mice. Neurobiology of Disease. 134: 104696. PMID 31783118 DOI: 10.1016/J.Nbd.2019.104696 |
0.436 |
|
2019 |
de Miguel E, Vekovischeva O, Elsilä LV, Panhelainen A, Kankuri E, Aitta-Aho T, Korpi ER. Conditioned Aversion and Neuroplasticity Induced by a Superagonist of Extrasynaptic GABA Receptors: Correlation With Activation of the Oval BNST Neurons and CRF Mechanisms. Frontiers in Molecular Neuroscience. 12: 130. PMID 31178693 DOI: 10.3389/fnmol.2019.00130 |
0.631 |
|
2017 |
Kopra JJ, Panhelainen A, Af Bjerkén S, Porokuokka LL, Varendi K, Olfat S, Montonen H, Piepponen TP, Saarma M, Andressoo JO. Dampened Amphetamine-Stimulated Behavior and Altered Dopamine Transporter Function in the Absence of Brain GDNF. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 37: 1581-1590. PMID 28096470 DOI: 10.1523/JNEUROSCI.1673-16.2016 |
0.357 |
|
2015 |
Kumar A, Kopra J, Varendi K, Porokuokka LL, Panhelainen A, Kuure S, Marshall P, Karalija N, Härma MA, Vilenius C, Lilleväli K, Tekko T, Mijatovic J, Pulkkinen N, Jakobson M, et al. GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function. Plos Genetics. 11: e1005710. PMID 26681446 DOI: 10.1371/journal.pgen.1005710 |
0.303 |
|
2015 |
Choi SJ, Panhelainen A, Schmitz Y, Larsen KE, Kanter E, Wu M, Sulzer D, Mosharov EV. Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure. The Journal of Biological Chemistry. 290: 6799-809. PMID 25596531 DOI: 10.1074/jbc.M114.631556 |
0.376 |
|
2014 |
Vashchinkina E, Panhelainen A, Aitta-Aho T, Korpi ER. GABAA receptor drugs and neuronal plasticity in reward and aversion: focus on the ventral tegmental area. Frontiers in Pharmacology. 5: 256. PMID 25505414 DOI: 10.3389/fphar.2014.00256 |
0.764 |
|
2012 |
Aitta-aho T, Möykkynen TP, Panhelainen AE, Vekovischeva OY, Bäckström P, Korpi ER. Importance of GluA1 subunit-containing AMPA glutamate receptors for morphine state-dependency. Plos One. 7: e38325. PMID 22675452 DOI: 10.1371/journal.pone.0038325 |
0.678 |
|
2012 |
Vashchinkina E, Panhelainen A, Vekovischeva OY, Aitta-aho T, Ebert B, Ator NA, Korpi ER. GABA site agonist gaboxadol induces addiction-predicting persistent changes in ventral tegmental area dopamine neurons but is not rewarding in mice or baboons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 5310-20. PMID 22496576 DOI: 10.1523/JNEUROSCI.4697-11.2012 |
0.79 |
|
2011 |
Panhelainen AE, Korpi ER. Evidence for a role of inhibition of orexinergic neurons in the anxiolytic and sedative effects of diazepam: A c-Fos study. Pharmacology, Biochemistry, and Behavior. 101: 115-24. PMID 22210490 DOI: 10.1016/j.pbb.2011.12.011 |
0.675 |
|
2011 |
Procaccini C, Aitta-aho T, Jaako-Movits K, Zharkovsky A, Panhelainen A, Sprengel R, Linden AM, Korpi ER. Excessive novelty-induced c-Fos expression and altered neurogenesis in the hippocampus of GluA1 knockout mice. The European Journal of Neuroscience. 33: 161-74. PMID 21073553 DOI: 10.1111/J.1460-9568.2010.07485.X |
0.758 |
|
Show low-probability matches. |